News Center

Letter to Registered Shareholders

Letter to Registered Shareholders

File size:

372.1KB

File Type:

pdf

2026-04-23

2026 First Quarterly Report

2026 First Quarterly Report

File size:

213.6KB

File Type:

pdf

2026-04-23

VOLUNTARY ANNOUNCEMENT THE NOTICE OF DRUG CLINICAL TRIAL APPROVAL OF JP-1366 TABLET

VOLUNTARY ANNOUNCEMENT THE NOTICE OF DRUG CLINICAL TRIAL APPROVAL OF JP-1366 TABLET

File size:

175.8KB

File Type:

pdf

2026-04-10

Date of Board Meeting

Date of Board Meeting

File size:

184.3KB

File Type:

pdf

2026-04-08

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2026

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2026

File size:

67.6KB

File Type:

pdf

2026-04-01

SUPPLEMENTAL ANNOUNCEMENT ON THE PROPOSED  PROFIT DISTRIBUTION PLAN FOR THE YEAR ENDED 31  DECEMBER 2025

SUPPLEMENTAL ANNOUNCEMENT ON THE PROPOSED PROFIT DISTRIBUTION PLAN FOR THE YEAR ENDED 31 DECEMBER 2025

File size:

134.8KB

File Type:

pdf

2026-03-26

VOLUNTARY ANNOUNCEMENT THE NOTICE OF DRUG CLINICAL TRIAL APPROVAL OF BREXPIPRAZOLE MICROSPHERES

VOLUNTARY ANNOUNCEMENT THE NOTICE OF DRUG CLINICAL TRIAL APPROVAL OF BREXPIPRAZOLE MICROSPHERES

File size:

176.0KB

File Type:

pdf

2026-03-26

ANNOUNCEMENT OF AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025

ANNOUNCEMENT OF AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025

File size:

7.0MB

File Type:

pdf

2026-03-25

Final Dividend for the year ended 31 December 2025

Final Dividend for the year ended 31 December 2025

File size:

494.8KB

File Type:

pdf

2026-03-25

POSITIONS HELD BY CURRENT DIRECTORS AT THE BOARD AND THE BOARD COMMITTEES

POSITIONS HELD BY CURRENT DIRECTORS AT THE BOARD AND THE BOARD COMMITTEES

File size:

151.9KB

File Type:

pdf

2026-03-25

< 1...567...160 > 跳转到 页